Blog
RSS FeedPosted by Michael Wonder on 22 May 2017
A vital drug runs low, though its base ingredient is in many kitchens
21 May 2017 - Hospitals around the country are scrambling to stockpile vials of a critical drug — even postponing ...
Posted by Michael Wonder on 22 May 2017
Drugs approved with limited data aren’t always well-tested later
19 May 2017 - New medicines that win U.S. marketing approval without conclusive evidence of their effectiveness aren't always proven ...
Posted by Michael Wonder on 22 May 2017
Democrats accuse White House of causing ACA tremors, then shifting blame
19 May 2017 - The on-again, off-again threat from the White House to shatter the Affordable Care Act appeared to ...
Posted by Michael Wonder on 22 May 2017
FDA approves first drug to specifically treat giant cell arteritis
22 May 2017 - The U.S. FDA today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat adults with ...
Posted by Michael Wonder on 22 May 2017
Pharma exec says industry must get fair about pricing new drugs
19 May 2017 - The head of Regeneron Pharmaceuticals is warning the controversy surrounding drug prices could cripple the country’s ...
Posted by Michael Wonder on 21 May 2017
Amgen submits biologics license application to the FDA for erenumab
18 May 2017 - Erenumab is an investigative treatment specifically designed to prevent migraine only molecule in late-stage development to ...
Posted by Michael Wonder on 20 May 2017
Rising insulin prices have diabetics crying foul
18 May 2017 - Insulin prices are only getting more painful. ...
Posted by Michael Wonder on 20 May 2017
Janssen files suit in U.S. to block sale of Samsung Bioepis' Remicade copy
18 May 2017 - A unit of healthcare conglomerate Johnson & Johnson filed a lawsuit to block a copy of ...
Posted by Michael Wonder on 20 May 2017
How did Vertex win an FDA approval without running a clinical trial?
19 May 2017 - Vertex Pharmaceuticals scored a minor coup this week when the Food and Drug Administration signed off ...
Posted by Michael Wonder on 20 May 2017
States get involved in lawsuit to shield Obamacare, saying Trump can’t be trusted
18 May 2017 - Attorneys general from 15 states and the District of Columbia filed a motion Thursday to intervene ...
Posted by Michael Wonder on 19 May 2017
Spark Therapeutics completes rolling biologics license application submission to FDA for investigational gene therapy voretigene neparvovec
18 May 2017 - Voretigene neparvovec has the potential to be the first pharmacologic treatment for an inherited retinal disease ...
Posted by Michael Wonder on 19 May 2017
Sage Therapeutics receives fast track designation for SAGE-217 for the treatment of major depressive disorder
18 May 2017 - Sage Therapeutics today announced that the U.S. FDA has granted fast track designation to SAGE-217 for ...
Posted by Michael Wonder on 18 May 2017
FDA approves Merck’s Keytruda (pembrolizumab) for certain patients with locally advanced or metastatic urothelial carcinoma, a type of bladder cancer
18 May 2017 - Keytruda is the only anti-PD-1 therapy to demonstrate superior overall survival versus chemotherapy in patients with advanced ...
Posted by Michael Wonder on 18 May 2017
Clinical trial participants should have a say in new drug pricing
18 May 2017 - People who volunteer to participate in clinical trials of new drugs provide a valuable service to ...
Posted by Michael Wonder on 18 May 2017
Low-income patients report better care and health after ACA passage, study finds
17 May 2017 - Public health researchers are still trying to understand the effects of the Affordable Care Act even ...